A novel homozygous ARFGEF2 splice-site variant causing periventricular nodular heterotopia with microcephaly
Frontiers in Pediatrics · 22.05.2026 · 14
DOI: 10.3389/fped.2026.1758158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 22.05.2026. Verfasst von Xuefang Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Neurology, Hebei Children's Hospital, Shijiazhuang, China. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The ARFGEF2 gene encodes the brefeldin A (BFA)-inhibited GEF2 protein (BIG2), which is distributed in the trans-Golgi network and plays a crucial role in neuronal proliferation and migration during cortical development through its regulation of vesicle transport. Pathogenic mutations in the ARFGEF2 gene are associated with autosomal recessive periventricular nodular heterotopia with microcephaly (ARPHM). To date, only slightly more than 20 cases have been reported worldwide. Herein, we presented a case of a patient with West syndrome who was ultimately diagnosed with ARPHM caused by a homozygous variant in the ARFGEF2 gene.
Methods
To identify disease-causing mutations, we performed exome sequencing (ES) of a child with West syndrome, and subsequently employed a minigene splicing assay to evaluate the functional impact of the ARFGEF2 gene splicing variant.
Results
The patient's clinical manifestations, examination results, treatment, and follow-up course were comprehensively documented. ES revealed a homozygous NM_006420.3: c.5181+1G>T variant in the ARFGEF2 gene. Subsequent functional analysis using a minigene splicing assay confirmed that this variant disrupts normal mRNA splicing, causing complete exon 38 skipping and a 118-bp deletion. The translation of this aberrant transcript is predicted to induce a frameshift, resulting in a truncated protein (p.Val1689SerfsTer20).
Conclusion
A novel pathogenic variant was identified by ES, and a minigene splicing assay established its disruptive impact on ARFGEF2 mRNA splicing. This study expands the genetic spectrum of ARFGEF2 and provides laboratory evidence for clinical diagnosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Department of Neurology, Hebei Children's Hospital, Shijiazhuang, China.
- First Department of Neurology, Hebei Provincial Clinical Research Center for Child Health and Disease, Shijiazhuang, China.
- First Department of Neurology, Hebei Provincial Key Laboratory for Pediatric Epilepsy and Neurological Disorders, Shijiazhuang, China.
Zitieren
APA
Liu, X., Pang, L., Li, J., Zhang, J., Wu, W., Li, X., Gong, Y., Dou, Y., Chen, F., & Sun, S. (2026). A novel homozygous ARFGEF2 splice-site variant causing periventricular nodular heterotopia with microcephaly. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1758158
Vancouver
Liu X, Pang L, Li J, Zhang J, Wu W, Li X, et al. A novel homozygous ARFGEF2 splice-site variant causing periventricular nodular heterotopia with microcephaly. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1758158
BibTeX
@article{Liu2026,
author = {Liu, Xuefang and Pang, Lingyu and Li, Jingjie and Zhang, Jing and Wu, Wenjuan and Li, Xin and Gong, Yubing and Dou, Yueying and Chen, Fang and Sun, Suzhen},
title = {A novel homozygous ARFGEF2 splice-site variant causing periventricular nodular heterotopia with microcephaly},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1758158}
}
EUVIMED